Multi OIT to Test Immune Markers After Minimum Maintenance Dose
Clinical trial NCT03181009 · COMPLETED
Trial details
- NCT number
- NCT03181009
- Sponsor
- Andrew Long, PharmD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2018-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.